{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T03:22:44Z","timestamp":1790997764908,"version":"4.1.0"},"reference-count":23,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T00:00:00Z","timestamp":1540166400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Bill and Melinda Gates Foundation (US)","award":["OPP1017832"],"award-info":[{"award-number":["OPP1017832"]}]}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0006830","type":"journal-article","created":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T17:32:41Z","timestamp":1540229561000},"page":"e0006830","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":21,"title":["Field safety and effectiveness of new visceral leishmaniasis treatment regimens within public health facilities in Bihar, India"],"prefix":"10.1371","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3564-129X","authenticated-orcid":true,"given":"Vishal","family":"Goyal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raman","family":"Mahajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishna","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shambhu Nath","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi Shankar","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Strub-Wourgaft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiana","family":"Alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vidya Nand","family":"Rabi Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roshan Kamal","family":"Topno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhawna","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manica","family":"Balasegaram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caryn","family":"Bern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allen","family":"Hightower","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suman","family":"Rijal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally","family":"Ellis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Temmy","family":"Sunyoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sakib","family":"Burza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nines","family":"Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pradeep","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Alvar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,10,22]]},"reference":[{"key":"ref1","unstructured":"World Health Organization. Weekly Epidemiological Record: Leishmaniasis in high-burden countries: an epidemiological update based in data reported in 2014. P287. Accessible at <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.who.int\/wer\/2016\/wer9122.pdf?ua=1\" xlink:type=\"simple\">http:\/\/www.who.int\/wer\/2016\/wer9122.pdf?ua=1<\/ext-link>. Accessed August 20, 2017."},{"issue":"5","key":"ref2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035671","article-title":"Leishmaniasis worldwide and global estimates of its incidence","volume":"7","author":"J Alvar","year":"2012","journal-title":"PLoS One"},{"key":"ref3","unstructured":"Programme NVBDCP. Kala-azar Cases and Deaths in the Country since 2010 [Internet]. 2017 [cited 2017 August 20]. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/nvbdcp.gov.in\/ka-cd.html\" xlink:type=\"simple\">http:\/\/nvbdcp.gov.in\/ka-cd.html<\/ext-link>"},{"issue":"3","key":"ref4","doi-asserted-by":"crossref","first-page":"471","DOI":"10.4269\/ajtmh.14-0743","article-title":"Amphotericin B Formulations and Other Drugs for Visceral Leishmaniasis","volume":"92","author":"J Berman","year":"2014","journal-title":"Am J Trop Med Hyg"},{"issue":"01","key":"ref5","first-page":"1","article-title":"An update on pharmacotherapy for leishmaniasis","volume":"16","author":"S Sundar","year":"2014","journal-title":"Expert Opin Pharmacother"},{"issue":"March","key":"ref6","first-page":"389","article-title":"Drug unresponsiveness &amp; combination therapy for kala-azar","volume":"123","author":"TK Jha","year":"2006","journal-title":"Indian J Med Res"},{"issue":"6","key":"ref7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0100220","article-title":"Failure of miltefosine treatment for visceral leishmaniasis in children and men in South-East Asia","volume":"9","author":"B Ostyn","year":"2014","journal-title":"PLoS One"},{"issue":"4","key":"ref8","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/cid\/cis474","article-title":"Jaya Chakravarty; Efficacy of Miltefosine in the Treatment of Visceral Leishmaniasis in India After a Decade of Use.","volume":"55","author":"Shyam Sundar","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"1","key":"ref9","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1093\/infdis\/jiu039","article-title":"Failure of miltefosine in visceral leishmaniasis is associated with low drug exposure","volume":"210","author":"TP Dorlo","year":"2014","journal-title":"J Infect Dis"},{"key":"ref10","article-title":"Jean-Claude Dujardin; Increasing Failure of Miltefosine in the Treatment of Kala-azar in Nepal and the Potential Role of Parasite Drug Resistance, Reinfection, or Noncompliance,","volume":"56","author":"Suman Rijal","year":"2013"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1056\/NEJMoa0903627","article-title":"Single-dose liposomal amphotericin B for visceral leishmaniasis in India","volume":"362","author":"S Sundar","year":"2010","journal-title":"N Engl J Med"},{"issue":"9764","key":"ref12","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0140-6736(10)62050-8","article-title":"Comparison of short-course multidrug treatment with standard therapy for visceral leishmaniasis in India: An open-label, non-inferiority, randomised controlled trial","volume":"377","author":"S Sundar","year":"2011","journal-title":"Lancet"},{"key":"ref13","first-page":"1","year":"2010"},{"issue":"9764","key":"ref14","first-page":"443","article-title":"Combination therapy for visceral leishmaniasis","volume":"2","author":"J Van Griensven","year":"2013","journal-title":"Int J Infect Microbiol"},{"issue":"2","key":"ref15","first-page":"443","article-title":"Combination therapy for visceral leishmaniasis","volume":"377","author":"M Banjara","year":"2011","journal-title":"Lancet"},{"issue":"3","key":"ref16","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S1473-3099(10)70011-6","article-title":"Combination therapy for visceral leishmaniasis","volume":"10","author":"J Van Griensven","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"ref17"},{"key":"ref18"},{"issue":"5","key":"ref19","doi-asserted-by":"crossref","first-page":"e0005635","DOI":"10.1371\/journal.pntd.0005635","article-title":"Safety and efficacy of short course combination regimens with AmBisome, miltefosine and paromomycin for the treatment of visceral leishmaniasis (VL) in Bangladesh","volume":"11","author":"R Rahman","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"ref20","article-title":"Drug Discovery for Leishmaniasis","volume":"218","author":"E Charles"},{"issue":"2","key":"ref21","first-page":"1031","article-title":"Mechanism of Amphotericin B Resistance in Clinical Isolates of Leishmania donovani.","volume":"56","author":"B Purkait","year":"2012"},{"key":"ref22","unstructured":"WHO Library Cataloguing-in-Publication Data Kala-Azar elimination programme: report of a WHO consultation of partners, Geneva, Switzerland, 10\u201311 February 2015."},{"key":"ref23"}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pntd.0006830","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T06:18:05Z","timestamp":1589005085000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0006830"}},"subtitle":[],"editor":[{"given":"Guilherme L.","family":"Werneck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,10,22]]},"references-count":23,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2018,10,22]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0006830","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,22]]}}}